EP1751352A1 - Tissue paper with protruding lotion deposits - Google Patents
Tissue paper with protruding lotion depositsInfo
- Publication number
- EP1751352A1 EP1751352A1 EP05741086A EP05741086A EP1751352A1 EP 1751352 A1 EP1751352 A1 EP 1751352A1 EP 05741086 A EP05741086 A EP 05741086A EP 05741086 A EP05741086 A EP 05741086A EP 1751352 A1 EP1751352 A1 EP 1751352A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tissue
- lotion
- paper
- deposits
- sqm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
- D21H27/02—Patterned paper
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
- D21C7/00—Digesters
- D21C7/14—Means for circulating the lye
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H19/00—Coated paper; Coating material
- D21H19/10—Coatings without pigments
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H23/00—Processes or apparatus for adding material to the pulp or to the paper
- D21H23/02—Processes or apparatus for adding material to the pulp or to the paper characterised by the manner in which substances are added
- D21H23/22—Addition to the formed paper
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H25/00—After-treatment of paper not provided for in groups D21H17/00 - D21H23/00
- D21H25/02—Chemical or biochemical treatment
Definitions
- the present invention relates to paper tissues, and products made from paper tissues. More particularly, the present invention relates to a tissue including lotion deposits having a significant height above the average plane of the tissue surface.
- Paper tissues sometimes called paper webs or sheets, tissues, tissue layers, paper plies or paper tissue webs, and products made there from, such as paper handkerchiefs, paper kitchen towel or bath tissue, toilet paper or facial tissues, find extensive use in modern society and are well known in the art.
- Paper tissues are generally made by the layering of cellulose fibers, in a wet form, onto a screen, with the addition of various additives or other ingredients, followed by a drying step. Other process steps, before, during or after the above-mentioned paper making steps are targeted at giving the desired properties to the tissue. Converting steps are aimed at creating a finished product from the paper tissue(s).
- Products made from paper tissues can be made by the association of multiple layers of paper tissues, also called plies, or can comprise a single paper tissue layer (single ply products). Those plies can be combined and held together in multiple ways to form the finished product, for example by embossing of the multi-ply structure or/and by gluing.
- the finished products are herein referred to as paper tissue products. Finished products made of more than one ply have internal tissue (or ply) surfaces, inwardly orientated, and 2 external surfaces, outwardly orientated. It has long been recognised that important physical attributes of these paper tissues are their strength and thickness/bulkiness, their softness and smoothness, and their absorbency.
- Softness and smoothness relate to the tactile sensation perceived by the consumer when holding a particular product, rubbing it across the skin, or crumpling it within the hands.
- Relatively thick and yet soft disposable paper products namely in the form of paper handkerchiefs, are known.
- TempoTM sold by The Procter & Gamble Company
- a high calliper conveys the idea of high dry and wet strength to the consumer.
- a high wet strength also referred to as wet burst strength, in particular prevents tearing or bursting which for a paper handkerchief in turn results in contamination of the user's hand with mucus or other body fluids.
- a common way to enhance the smoothness of the tissue surface is to calender the material.
- Another way to improve the sensation of smoothness perceived by the users of paper tissue products, such as handkerchiefs, is to complement the composition of the paper tissue with some additives during the paper-making phase and/or during the converting phase.
- Those additives can have the effect of smoothening the paper tissue in a way that makes the user feel it more soft or smooth.
- some additives have an effect on the skin of the user touching or using the paper tissue product, e.g.
- Smoothening lotions are usually of hydrophobic nature or contain hydrophobic compounds.
- the presence of the lotion at the surface of the paper tissue can have adverse effects on the properties of the paper tissue :
- the masking of the hydrophilic tissue surface by an hydrophobic lotion can reduce the absorbency of tissue or the speed of absorbency. This present a undesirable effect for the user. For example, one a paper handkerchief, the nasal mucus can take a longer time to be absorbed by a lotioned paper tissue than by a non lotioned one.
- the lotion can migrate from tissue the surface thru the paper tissue structure making the paper tissue less hydrophilic and making less lotion available at the surface to deliver the smoothening benefits to the skin.
- a traditional way to respond to that expected migration of the lotion over time is to use a relatively high amount of lotion to insure a certain availability of the lotion on the surface of the tissue, even after extended storage. In turn this creates an excess of lotion on the freshly produced paper tissues thus triggering a negative greasy feeling during use (and reducing further more the absorbency of the paper tissue).
- lotions that are coating the fibers are less susceptible to be released by the tissue during use and thus less transferable to the skin of the user.
- the present invention provides a paper tissue having first and second opposed surfaces wherein the tissue includes a lotion on at least one surface of the paper tissue.
- the lotion is present in substantially discrete protruding deposits on the first surface, wherein the paper tissue has a bulk of equal or less than 5.2 cm 3 /g of tissue wherein the protruding deposits have an average height of at least 30 ⁇ m.
- Figure 1 is a representation of the elevations at the surface of the tissue of example 1.
- the tissue is treated with 2.1g/sqm of lotion.
- Figure 2 is a representation of the tissue surface of tissue example 1, treated with the formulation of example 1 at 2.1g/sqm, showing the height of the protruding deposits in grey values. White areas are protruding.
- the present invention provides a paper tissue exhibiting a high level of surface smoothness and softness, high absorbency, a high strength and a high bulkiness. These apparently competing characteristics have been combined by following the concept of the present invention.
- a "lotion" a composition added to the tissue preferably at the converting phase in order to improved its softness / smoothness and have smoothening effect on the skin.
- the lotion can transfer from the tissue to the user's skin upon use of the paper tissue article. It thus induces a longer term smoothening effect on the skin.
- Lotion can be called alternatively smoothening or softening lotion or composition.
- the lotion may comprise softening / debonding agents, emollients, immobilizing agents and mixtures thereof. Suitable softening / debonding agents include quaternary ammonium compounds, polysiloxanes, and mixtures thereof.
- Suitable emollients include propylene glycol, glycerine, triethylene glycol, spermaceti or other waxes, petrolatum fatty acids, fatty alcohols and fatty alcohol ethers having from 12 to 28 carbon atoms in their fatty acid chain, mineral oil, namely silicone oil e.g. dimethicone and isopropyl palmitrat, and mixtures thereof.
- Suitable immobilizing agents include waxes, fatty alcohols, fatty acids, e.g. ceresin wax, microcrystalline wax, petroleum waxes, fisher tropsh waxes, paraffin waxes, stearyl alcohol and paraffins, polyhydroxy fatty acid esters, polyhydroxy fatty acid amides, and mixtures thereof.
- the lotions contain at least one immobilizing agent and an emollient.
- Lotions can be emulsions or dispersions.
- Other optional components include perfumes, antibacterial actives, antiviral actives, disinfectants, pharmaceutical actives, film formers, deodorants, opacifiers, astringents, solvents and the like.
- Particular examples of lotion components include camphor, thymol, menthol, chamomile extracts, aloe vera, calendula officinalis.
- "Protruding deposit” means a protruding deposit is defined as a deposition of lotion on the paper tissue that protrudes (in some embodiments, at least 25 micrometers) above the average plane of the tissue surface.
- tissue height of protruding deposits means average of the height of each data point (provided by the method described thereafter) that are at least 25 micrometers above the average plane of the tissue surface.
- paper tissue means average of the height of each data point (provided by the method described thereafter) that are at least 25 micrometers above the average plane of the tissue surface.
- paper tissue means average of the height of each data point (provided by the method described thereafter) that are at least 25 micrometers above the average plane of the tissue surface.
- paper tissue paper tissue web
- tissue web tissue web
- tissue web tissue web
- tissue tissue and web
- the present invention is useful with tissue paper in general, including but not limited to conventionally felt-pressed tissue paper; high bulk pattern densified tissue paper; and high bulk, uncompacted tissue paper and through-air dried paper.
- the tissue paper can be of a homogenous or multi-layered construction; and tissue paper products made therefrom can be of a single-ply or multiply construction.
- the tissue paper preferably has a basis weight of between about 10 g/m 2 and about 65 g/m 2 , and bulk of about 5.2 cm3/g or less (preferably equal or less than 5.0 cm3/g). More preferably, the basis weight will be about 40 g/m 2 or less.
- Conventionally pressed tissue paper and methods for making such paper are well known in the art. Such paper is typically made by depositing a papermaking furnish on a foraminous forming wire, often referred to in the art as a Fourdrinier wire. Once the furnish is deposited on the forming wire, it is referred to as a web. The web is dewatered by pressing the web and drying at elevated temperature.
- the dewatered web is then further pressed and dried by a steam drum apparatus known in the art as a Yankee dryer.
- Applicable wood pulps include chemical pulps, such as Kraft, sulfite, and sulfate pulps, as well as mechanical pulps including, for example, groundwood, thermomechanical pulp and chemically modified thermomechanical pulp.
- the papermaking furnish used to make tissue paper structures can have other components or materials added thereto as can be or later become known in the art.
- the types of additives desirable will be dependent upon the particular end use of the tissue sheet contemplated. For example, in products such as toilet paper, paper towels, facial tissues and other similar products, high wet strength is a desirable attribute.
- Paper tissue of the present invention can have a moisture content of between 0 and 20% (w/w) but it has been found that best results are obtained with a moisture level of at least 4% (w/w).
- the paper tissue of the present invention can be formed from a unique layer of material or can be a multi-layered tissue paper web.
- multi-layered tissue paper web, multi-layered paper web, multi-layered web, multi-layered paper sheet and multi-layered paper product are all used interchangeably in the art to refer to sheets of paper prepared from two or more layers of aqueous paper making furnishes which are preferable comprised of different fiber types, the fibers typically being relatively long softwood and relatively short hardwood fibers as used in tissue paper making.
- the layers are preferable formed from the deposition of separate streams of dilute fiber slurries upon one or more endless foraminous surfaces. If the layers are initially formed on separate foraminous surfaces, the layers can subsequently combined when wet to form a multi- layered tissue paper web.
- the "paper tissue products” of this invention are the finished products such a kitchen towels or paper handkerchiefs, made out of one or multiple plies of the above described paper tissues.
- Each ply of a multiply paper product can be made of diverse material or been manufactured in diverse ways at the paper making or converting steps.
- the term "single-ply tissue product” means that it is comprised of one ply of tissue; the ply can be substantially homogeneous in nature or it can be a multi-layered tissue paper web.
- the term "multi-ply tissue product” means that it is comprised of more than on ply of tissue.
- the plies of a multi-ply tissue product can be substantially homogeneous in nature of they can be multi-layered tissue paper webs.
- “Lotion basis weight of the protruding deposits” is the concentration of lotion, expressed in grams per square meter, within the protruding deposits of lotion on the tissue. This is an average value of the deposits measured.
- the lotion basis weight of the protruding deposits is determined as described in the method below.
- “Density of the protruding deposits” is the average number of protruding lotion deposits per area of tissue, expressed in sqcm “1 .
- “Lotion basis weight of the tissue” is the overall concentration of lotion, expressed in grams per square meter, of lotion on the tissue (also referred as total or overall basis weight or concentration). The basis weight can be measured by any standard method, e.g.
- the careful selection the distribution of the lotion on the tissue, as multitude of discrete deposits, can enhance the transferability of the lotion from the tissue onto the skin of the user. It is believed that protruding deposing having a significant height above the average plan of the tissue surface will have a higher transferability to the skin of the user and thus will contribute best to the general smoothness of the tissue. It has been found that deposits protruding at least 25 ⁇ m above the average plan of the tissue surface are most beneficial.
- the deposits protrude at least 30 ⁇ m, 35 ⁇ m or at least 50 ⁇ m.
- the beneficial effects have been best observed when the protruding deposits are applied on the tissue paper of limited bulk (i.e. less than 5.2 cmVg, or 5.0 cmVg).
- the total basis weight of lotion on the tissue is equal or less than 9 g/sqm, less than 6g/sqm, less than 4.5g/sqm, 3.0g/sqm and most preferably less than 2g/sqm.
- a ratio R is considered : Lotion basis weight of the protruding deposits (g/sqm) lotion basis weight of the tissue (g/sqm) The beneficial effects are observed when R is greater than 0.005.
- R can also be 0.01, 0.02, 0.05, 0.1, 0.2, or 0.3 in preferred embodiments. It has been observed that the beneficial effects are obtain in some embodiments when the density of protruding deposits is at least 1, 3, 5 or 10 per sqcm of tissue.
- the lotion can be visualized by osmium tetroxide staining, described herein. In other embodiments, the lotion can be visualized by Infrared spectroscopy (IR spectroscopy), which method is referenced herein.
- the total basis weight of lotion on the tissue is generally at least 0.3 g/sqm, 0.6 g/sqm, 1.0 g/sqm, 1.5g/sqm or2.5 g/sqm
- the ratio R 2 wherein Area of the protruding deposits measured at the threshold value of claim 1 (mm ⁇ 2)
- R 2 Area of the tissue (mm ⁇ 2) * Lotion weight of the tissue (g/sqm)
- R 2 is at least 0.005, 0.001, at least 0.05 or at least 0.08.
- the invention is related to a multiply tissue product.
- the multiply tissue product comprises 2 plies
- the invention works well when at least one of the external surfaces (outwardly orientated surfaces) has more lotion than its corresponding internal surface (inwardly orientated surfaces). This can be determined by scanning electron microscopy.
- the multiply tissue product has at least 3 plies, it has been found that the lotion transferability is suitable when at least 60%, at least 70 % at least 80% or at least 90% of the lotion is located one of the outer plies. Indeed, the lotion present on the inner ply(ies) contributes much less in the transfer of the lotion to the users skin.
- Lotion The present invention as described here particularly focuses on smoothening lotion.
- additives or compound could be applied by the described process, as long as the physical characteristics (e.g. melting point, viscosity), and the application temperature are adjusted to obtain the desired distribution pattern of the applied additives or compounds at the surface of the paper tissue.
- additives or compounds could include: hydration lotion, soap, moisturizers, sun-protection, make-up removal ingredients, anti-aging, disinfectants, or more generally additives/compounds in the cosmetic and therapeutic fields, detergents, soaps, waxes, cleaning additives and more generally compounds for the cleaning, maintenance, protection and treatment of objects, surfaces or mechanical parts. Lotions are in most instances of heterogeneous composition.
- melting temperature i.e. difficult to determine the temperature of transition between the liquid form, the quasi-liquid from, the quasi-solid form and the solid form.
- melting temperature melting point, transition point and transition temperature are used interchangeably in this document and have the same meaning. For the purpose of this invention it is considered that not only the melting temperature relates to the definition of the form or state of the lotion (liquid, solid, quasi- liquid, quasi-solid), but also its rheological properties.
- liquid or quasi-liquid lotion are able to flow, move, and migrate, for example under the force encountered during the process of application.
- Solid or quasi- solid lotions are not able to flow freely and are somewhat immobilized at their location.
- a lotion will be said liquid or quasi-liquid if it can be fed onto the rotating surfaces and expulsed there from under the used process conditions.
- a lotion will be said solid or semi-solid if it does not significantly freely migrates from the surface into the inner structure of the tissue at room temperature, i.e. 23°C until the product is usually used.
- the lotion may comprise a surface treating agent.
- Nonlimiting examples of suitable surface treating agents that may be included in the lotion can be selected from the group consisting of: polymers such as polyethylene and derivatives thereof, hydrocarbons, waxes, oils, silicones (polysiloxanes), quaternary ammonium compounds, fluorocarbons, substituted C ⁇ 0 -C 2 alkanes, substituted C 10 -C 2 alkenes, in particular derivatives of fatty alcohols and fatty acids(such as fatty acid amides, fatty acid condensates and fatty alcohol condensates), polyols, derivatives of polyols (such as esters and ethers), sugar derivatives (such as ethers and esters), polyglycols (such as polyethyleneglycol) and mixtures thereof.
- polymers such as polyethylene and derivatives thereof, hydrocarbons, waxes, oils, silicones (polysiloxanes), quaternary ammonium compounds, fluorocarbons, substituted C ⁇ 0 -C 2 alkan
- the lotion may comprise oils and/or emollients and/or waxes (any and all of which may be a transferable agent) and/or immobilizing agents.
- the lotion comprises from about 10% to about 90% of an oil and/or liquid emollient and from about 10% to about 50% of immobilizing agent and/or from about 0% to about 60% of petrolatum and optionally the balance of a vehicle.
- the lotion may be heterogeneous. They may contain solids, gel structures, polymeric material, a multiplicity of phases (such as oily and water phase) and/or emulsified components. It may be difficult to determine precisely the melting temperature of the lotion, i.e.
- the lotion may be semi-solid, of high viscosity so they do not substantially flow without activation during the life of the product or gel structures.
- the lotion may be shear thinning and/or they may strongly change their viscosity around skin temperature to allow for transfer and easy spreading on a user's skin.
- the lotion may be in the form of emulsions and/or dispersions.
- the lotion has a water content of less than about 20% and/or less than 10% and/or less than about 5% or less than about 0.5%.
- the lotion may have a solids content of at least about 15% and/or at least about 25% and/or at least about 30% and/or at least about 40% to about 100%) and/or to about 95% and/or to about 90% and/or to about 80%.
- Nonlimiting examples of suitable oils and/or emollients include glycols (such as propylene glycol and/or glycerine), polyglycols (such as triethylene glycol), petrolatum, fatty acids, fatty alcohols, fatty alcohol ethoxylates, fatty alcohol esters and fatty alcohol ethers, fatty acid ethoxylates, fatty acid amides and fatty acid esters, hydrocarbon oils (such as mineral oil), squalane, fluorinated emollients, silicone oil (such as dimethicone) and mixtures thereof.
- glycols such as propylene glycol and/or glycerine
- polyglycols such as triethylene glycol
- petrolatum such as propylene glycol and/or glycerine
- fatty acids such as propylene glycol and/or glycerine
- fatty alcohol ethoxylates such as fatty alcohol esters and fatty alcohol ethers
- Immobilizing agents include agents that are may prevent migration of the emollient into the paper tissue such that the emollient remain primarily on the surface of the paper tissue and/or sanitary tissue product and/or on the surface treating composition on a surface of the paper tissue and/or sanitary tissue product and facilitate transfer of the lotion to a user's skin. Immobilizing agents may function as viscosity increasing agents and/or gelling agents.
- suitable immobilizing agents include waxes (such as ceresin wax, ozokerite, microcrystalline wax, petroleum waxes, fisher tropsh waxes, silicone waxes, paraffin waxes), fatty alcohols (such as cetyl and/or stearyl alcohol), fatty acids and their salts (such as metal salts of stearic acid), mono and polyhydroxy fatty acid esters, mono and polyhydroxy fatty acid amides, silica and silica derivatives, gelling agents, thickeners and mixtures thereof.
- the lotion comprises at least one immobilizing agent and at least one emollient.
- the lotion comprises a sucrose ester of a fatty acid.
- the lotion may be comprise a transferable agent and thus be considered a transferable lotion.
- a transferable lotion comprises at least one transferable agent that is capable of being transferred to an opposing surface such as a user's skin upon use. In one example, at least 0.1%) of the transferable lotion present on the user contacting surface transfers to the user's skin during use.
- the amount of transferable composition that transfers to a user's skin during use can be determined by known methods such as by tape stripping the skin 3 times, after use of the paper tissue and/or sanitary tissue product by the user, with Tegaderm Tapes, available from 3M, and analyzing the tapes for the transferable composition or a component within the transferable composition assuming all components of the transferable composition transfer equally.
- lotion components include vehicles, perfumes, especially long lasting and/or enduring perfumes, antibacterial actives, antiviral actives, disinfectants, pharmaceutical actives, film formers, deodorants, opacif ⁇ ers, astringents, solvents, cooling sensate agents, and the like.
- lotion components include camphor, thymol, menthol, chamomile extracts, aloe vera, calendula officinalis, alpha bisalbolol, Vitamin E, Vitamin E acetate.
- the lotion is present on the surface of the paper tissue and/or sanitary tissue product and/or on the surface treating composition present on the surface of the paper tissue and/or sanitary tissue product at a level of at least about 0.5 g/m 2 and/or at least about 1.0 g/m 2 and/or at least about 1.5 g/m 2 per user contacting surface.
- the lotion is present on the surface of the paper tissue and/or sanitary tissue product and/or on the surface treating composition present on the surface of the paper tissue and/or sanitary tissue product at a level of from about 0.5 g/m 2 and or from about 1.0 g/m 2 and/or from about 1.5 g/m 2 to about 10 g/m 2 and/or to about 8 g/m 2 and/or to about 6 g/m 2 per user contacting surface.
- a "vehicle” is a material that can be used to dilute and/or emulsify agents forming the surface treating composition and/or lotion to form a dispersion/emulsion.
- a vehicle may be present in the surface treating composition and/or lotion, especially during application of the surface treating composition and/or to the paper tissue.
- a vehicle may dissolve a component (true solution or micellar solution) or a component may be dispersed throughout the vehicle (dispersion or emulsion).
- the vehicle of a suspension or emulsion is typically the continuous phase thereof. That is, other components of the dispersion or emulsion are dispersed on a molecular level or as discrete particles throughout the vehicle.
- Suitable materials for use as the vehicle of the present invention include hydroxyl functional liquids, including but not limited to water.
- the lotion comprises less than about 20% and/or less than about 10% and/or less than about 5% and/or less than about 0.5% w/w of a vehicle, such as water.
- the surface treating composition comprises greater than about 50% and/or greater than about 70% and/or greater than about 85% and or greater than about 95% and/or greater than about 98% w/w of a vehicle, such as water. It has been found that a suitable lotion of the present invention has a water content of less than 20%, less than 10%, less than 5% or less than 0.5%.
- Example 1 of lotion formulation It has been found that the present invention is of particular efficacy when the lotion has the following composition (in weight/weight percent) :
- Example 2 of lotion formulation It has been found that the present invention is of particular efficacy when the lotion has the following composition (in weight/weight percent) :
- Example 3 of lotion formulation It has been found that the present invention is of particular efficacy when the lotion has the following composition (in weight/weight percent) : Stearyl Alcohol CO 1897 20% SEFOSE 1618S** 80% * Available from Procter&Gamble Chemicals, Cincinnati, USA ** Sucrose esters of fatty alcohols, available from Procter&Gamble Chemicals, Cincinnati, USA
- the tissue paper used in the following examples is a conventional wet pressed, homogeneous, dry creped tissue paper with a basis weight of about 15.4 g/sqm.
- the paper web has a composition of about 40% Northern Softwood Kraft and 60% Eucalyptus.
- four sheets of paper are combined together in an off line combining operation.
- the pre-combined 4-ply parent roll is subsequently converted into a 4-ply tissue product.
- the 4-ply parent roll is unwound and subjected to calandering between two smooth steel calender rolls followed by high pressure embossing to achieve ply bonding.
- the majority of the tissue paper remains unaffected by the high pressure embossing.
- the 4-ply paper tissue product obtained by the above described process had a basis weight of approximately 60g/sqm (not including any lotion applied), a thickness of 0.27mm, a bulk of 4.5 cm3/g, a machine direction strength of 1280 g/in, a cross direction strength of 610 g/in, and a wet burst of about 200g. It contained a wet strength agent and a dry strength agent.
- tissue paper used in the following examples is a conventional wet pressed, layered, dry creped tissue paper with a basis weight of about 14.6 g/sqm.
- the outer layer contains about 100% Eucalyptus fiber whereas the inner layer is composed of a furnish mix of about 85% Northern Softwood Kraft, 10% CTMP and about 5% Eucalyptus fiber. Both layers are of about equal basis weight (symmetrical layer split).
- four sheets of paper are combined together in an off line combining operation. The pre-combined 4-ply parent roll is subsequently converted into a 4-ply tissue product.
- the 4-ply parent roll is unwound and subjected to calendering between two smooth steel calender rolls followed by high pressure embossing to achieve ply bonding.
- the majority of the tissue paper remains unaffected by the high pressure embossing.
- the tissue was cut in machine direction, followed by cutting in cross direction into sheets of approximately 21cm x 21cm, folded, stacked into stacks of 9 sheets and packed into individual pocket packs.
- the 4-ply paper tissue product obtained by the above described process has a basis weight of approximately 60g/sqm (not including any lotion applied), a thickness of 0.27mm, a bulk of 4.5 cm3/g, a machine direction strength of 1180 g/in, a cross direction strength of 560 g/in, and a wet burst of about 200g. It contains a wet strength agent and a dry strength agent.
- Methods Bulk of the tissue paper : The bulk of the tissue is defined as the reciprocal value of the density (in g/cm3). See column 13, lines 61-67 of US patent 5,059,282 (Ampulski et al), issued October 22 1991 which describes how the density of tissue paper is measured.
- Average lotion add-on level by solvent extraction (basis weight of lotion on the tissue) : A representative sample of about 2g of the lotion treated tissue is extracted by Accellerated Solvent Extraction (ASE) using a model ASE 200, available from Dionex Corp., USA. The following conditions are used: 11ml extraction cell, solvent mixture: 50 % Acetone/n-Hexane; temperature: 100°C (heat and static 5 minutes); pressure: 1000 PSI; two cycles with 100 % flush. The solvent is evaporated and the residue is determined gravimetrically. The lotion add on is then calculated as
- Average lotion Weight of the extract in [g] x Basis weight of the sample in f g/sqm] add on in g/sqm Weight of the sample before extraction in [g]
- Osmium Staining A square sample of tissue of about 4cm x 4cm is cut from a flat, unembossed and unfolded area of the tissue product to be analyzed ( a smaller area can be used if needed). All tissue samples are placed in open containers equidistant from an open container of 10ml of a 4% OSO ⁇ solution (in water) under a glass staining dome in a hood. The vapor staining is done typically for 24 hours. The duration of staining is not very critical and can be longer or shorter depending on the affinity of the lotion for osmium and the desired level of "blackness". Staining is stopped when the best possible contrast in the sample between lotion spots and substrate is reached.
- Sample Preparation for Surface Analysis The sample tissue is placed on a 2 inch x 3 inch (about 5cm x 7.6cm) glass slide with the surface that is to be analyzed, facing up. The edges of the ply were carefully taped to the slide to produce a flat sheet.
- Surface Analysis The mounted samples described above were analyzed by a GFM Primos optical 3D measuring system (Teltow, Germany) which is based on the digital stripe projection technique. The system has a field of view of 2.7x2.
- the operating software was Primos version 4.074. If possible the full field view should be used, only if the sample does not contain a large enough flat, unfolded and unembossed area should a smaller field of view is to be used for analysis.
- the system produces a grayscale camera image (GS image) for each sample analyzed as well as a 3D surface height image (3D image) calibrated in microns.
- the GS image was exported from the Primos software as a BMP image for further processing.
- the 3D image was processed using the Primos software Align function which removes tilt and exported as a Fringe File Version 1 format (FD3).
- This binary mask (BM) shows 1 's where there is darkly stained lotion and zeros everywhere else.
- AnalySIS (available from Soft Imaging GmbH, Germany) as described in the US patent application cited above, by setting all pixels with a local lotion basis weight of lOg/sqm to "1" in the binary mask BM and all other points to "0".
- Appropriate fudicial marks within the image can be used to register the binary mask with the 3D height image.
- FC final composite image
- the lotion basis weight of the protruding deposits (in g/sqm) is obtained from the mean volume of the deposits per area multiplied by the density of the lotion.
- the ratio R is then calculated by dividing the lotion basis weight of the deposits (in g/sqm) by the lotion basis weight of the tissue (in g/sqm).
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56510404P | 2004-04-23 | 2004-04-23 | |
PCT/US2005/014090 WO2005106122A1 (en) | 2004-04-23 | 2005-04-25 | Tissue paper with protruding lotion deposits |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1751352A1 true EP1751352A1 (en) | 2007-02-14 |
EP1751352B1 EP1751352B1 (en) | 2009-09-16 |
Family
ID=34967194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05741086A Not-in-force EP1751352B1 (en) | 2004-04-23 | 2005-04-25 | Tissue paper with protruding lotion deposits |
Country Status (10)
Country | Link |
---|---|
US (1) | US20050238682A1 (en) |
EP (1) | EP1751352B1 (en) |
JP (1) | JP5118483B2 (en) |
CN (2) | CN1946903A (en) |
AT (1) | ATE443181T1 (en) |
AU (1) | AU2005238503B2 (en) |
CA (1) | CA2563939C (en) |
DE (1) | DE602005016673D1 (en) |
MX (1) | MXPA06012195A (en) |
WO (1) | WO2005106122A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080008865A1 (en) * | 2006-06-23 | 2008-01-10 | Georgia-Pacific Consumer Products Lp | Antimicrobial hand towel for touchless automatic dispensers |
US8940323B2 (en) * | 2008-05-30 | 2015-01-27 | Kimberly-Clark Worldwide, Inc. | Tissue products having a cooling sensation when contacted with skin |
WO2014025665A2 (en) * | 2012-08-06 | 2014-02-13 | The Procter & Gamble Company | Folded and lotioned web products |
FI126174B (en) | 2012-12-04 | 2016-07-29 | Valmet Automation Oy | Measurement of tissue paper |
JP6188855B1 (en) * | 2016-03-31 | 2017-08-30 | 大王製紙株式会社 | Tissue paper |
CN106120477A (en) * | 2016-06-28 | 2016-11-16 | 郭迎庆 | A kind of preparation method of slow release medicine carrying paper mulch sheet |
US11053643B2 (en) | 2017-02-22 | 2021-07-06 | Kimberly-Clark Worldwide, Inc. | Layered tissue comprising non-wood fibers |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994771A (en) * | 1975-05-30 | 1976-11-30 | The Procter & Gamble Company | Process for forming a layered paper web having improved bulk, tactile impression and absorbency and paper thereof |
ATE8282T1 (en) * | 1979-07-05 | 1984-07-15 | Sir James Farmer Norton & Co. Limited | APPLICATION OF LIQUIDS TO TEXTILE PRODUCTS. |
US4300981A (en) * | 1979-11-13 | 1981-11-17 | The Procter & Gamble Company | Layered paper having a soft and smooth velutinous surface, and method of making such paper |
FR2712188B1 (en) * | 1993-11-08 | 1996-01-26 | Oreal | Cosmetic composition intended for making up the skin, its preparation process and make-up product obtained from said composition. |
AU1295895A (en) * | 1993-12-13 | 1995-07-03 | Procter & Gamble Company, The | Lotion composition for imparting soft, lubricious feel to tissue paper |
US6238682B1 (en) * | 1993-12-13 | 2001-05-29 | The Procter & Gamble Company | Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation |
JP4169783B2 (en) * | 1994-06-17 | 2008-10-22 | ザ プロクター アンド ギャンブル カンパニー | Tissue paper with lotion |
US5885697A (en) * | 1996-12-17 | 1999-03-23 | Kimberly-Clark Worldwide, Inc. | Soft treated tissue |
US5814188A (en) * | 1996-12-31 | 1998-09-29 | The Procter & Gamble Company | Soft tissue paper having a surface deposited substantive softening agent |
US6231719B1 (en) * | 1996-12-31 | 2001-05-15 | Kimberly-Clark Worldwide, Inc. | Uncreped throughdried tissue with controlled coverage additive |
US6217707B1 (en) * | 1996-12-31 | 2001-04-17 | Kimberly-Clark Worldwide, Inc. | Controlled coverage additive application |
US5871763A (en) * | 1997-04-24 | 1999-02-16 | Fort James Corporation | Substrate treated with lotion |
EP0994933A4 (en) * | 1997-05-30 | 2000-07-05 | Oded Broshi | An edible, pleasant tasting, bubble making composition |
US5869075A (en) * | 1997-08-15 | 1999-02-09 | Kimberly-Clark Worldwide, Inc. | Soft tissue achieved by applying a solid hydrophilic lotion |
US6261580B1 (en) * | 1997-10-22 | 2001-07-17 | The Procter & Gamble Company | Tissue paper with enhanced lotion transfer |
US6187695B1 (en) * | 1998-12-08 | 2001-02-13 | Kimberly-Clark Worldwide, Inc. | Cool feeling tissue product and method |
US6544386B1 (en) * | 1999-12-27 | 2003-04-08 | Kimberly-Clark Worldwide, Inc. | Ply bonded lotion treated tissue and method for making same |
US6432268B1 (en) * | 2000-09-29 | 2002-08-13 | Kimberly-Clark Worldwide, Inc. | Increased hydrophobic stability of a softening compound |
US6756520B1 (en) * | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
US6860967B2 (en) * | 2001-01-19 | 2005-03-01 | Sca Hygiene Products Gmbh | Tissue paper penetrated with softening lotion |
ATE371055T1 (en) * | 2001-02-16 | 2007-09-15 | Procter & Gamble | EMBOSSED AND LOTION-TREATED TISSUE PAPER |
US6805965B2 (en) * | 2001-12-21 | 2004-10-19 | Kimberly-Clark Worldwide, Inc. | Method for the application of hydrophobic chemicals to tissue webs |
US6716309B2 (en) * | 2001-12-21 | 2004-04-06 | Kimberly-Clark Worldwide, Inc. | Method for the application of viscous compositions to the surface of a paper web and products made therefrom |
US6758943B2 (en) * | 2001-12-27 | 2004-07-06 | Kimberly-Clark Worldwide, Inc. | Method of making a high utility tissue |
AU2003228467A1 (en) * | 2002-04-19 | 2003-11-03 | Evco Research, Llc | Moisture resistant, repulpable paper products and method of making same |
US6752905B2 (en) * | 2002-10-08 | 2004-06-22 | Kimberly-Clark Worldwide, Inc. | Tissue products having reduced slough |
US6761800B2 (en) * | 2002-10-28 | 2004-07-13 | Kimberly-Clark Worldwide, Inc. | Process for applying a liquid additive to both sides of a tissue web |
US6861380B2 (en) * | 2002-11-06 | 2005-03-01 | Kimberly-Clark Worldwide, Inc. | Tissue products having reduced lint and slough |
US6887350B2 (en) * | 2002-12-13 | 2005-05-03 | Kimberly-Clark Worldwide, Inc. | Tissue products having enhanced strength |
US6896766B2 (en) * | 2002-12-20 | 2005-05-24 | Kimberly-Clark Worldwide, Inc. | Paper wiping products treated with a hydrophobic additive |
-
2005
- 2005-04-09 CN CNA2005800124018A patent/CN1946903A/en active Pending
- 2005-04-14 US US11/105,975 patent/US20050238682A1/en not_active Abandoned
- 2005-04-25 AU AU2005238503A patent/AU2005238503B2/en not_active Ceased
- 2005-04-25 CN CNB2005800128305A patent/CN100567639C/en not_active Expired - Fee Related
- 2005-04-25 DE DE602005016673T patent/DE602005016673D1/en active Active
- 2005-04-25 MX MXPA06012195A patent/MXPA06012195A/en active IP Right Grant
- 2005-04-25 CA CA2563939A patent/CA2563939C/en not_active Expired - Fee Related
- 2005-04-25 EP EP05741086A patent/EP1751352B1/en not_active Not-in-force
- 2005-04-25 AT AT05741086T patent/ATE443181T1/en not_active IP Right Cessation
- 2005-04-25 WO PCT/US2005/014090 patent/WO2005106122A1/en active Application Filing
- 2005-04-25 JP JP2007509714A patent/JP5118483B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO2005106122A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20050238682A1 (en) | 2005-10-27 |
AU2005238503B2 (en) | 2008-03-13 |
AU2005238503A1 (en) | 2005-11-10 |
WO2005106122A1 (en) | 2005-11-10 |
JP5118483B2 (en) | 2013-01-16 |
JP2007533416A (en) | 2007-11-22 |
ATE443181T1 (en) | 2009-10-15 |
CN1946905A (en) | 2007-04-11 |
DE602005016673D1 (en) | 2009-10-29 |
CA2563939A1 (en) | 2005-11-10 |
MXPA06012195A (en) | 2007-01-17 |
EP1751352B1 (en) | 2009-09-16 |
CA2563939C (en) | 2012-01-24 |
CN100567639C (en) | 2009-12-09 |
CN1946903A (en) | 2007-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2563593C (en) | Paper tissue with high lotion transferability | |
CA2563939C (en) | Tissue paper with protruding lotion deposits | |
EP1244855A1 (en) | A method of applying treatment chemicals to a fiber-based planar product via a revolving belt and planar products made using said method | |
AU2005238471B2 (en) | Fibrous structures comprising a transferable agent | |
CA2563539C (en) | Fibrous structures comprising a surface treating composition and a lotion composition | |
WO2001049933A2 (en) | A method of applying treatment chemicals to a fiber-based planar product and products obtained by said method | |
US20050238699A1 (en) | Fibrous structures comprising a surface treating composition and lotion composition | |
US20020187269A1 (en) | Method of applying treatment chemicals to fiber-based planer products and products made using same | |
WO2001049936A1 (en) | Method of applying chemicals to fibrous products | |
US20020001728A1 (en) | Method of layer-by-layer application of treatment chemicals to fiber-based planar products and products made using same | |
CA2393205C (en) | Article such as a make-up removal pad comprising an external surface for applying aqueous products on the skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20061101 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
17Q | First examination report despatched |
Effective date: 20070427 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 602005016673 Country of ref document: DE Date of ref document: 20091029 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20090916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100118 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091227 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
26N | No opposition filed |
Effective date: 20100617 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100430 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100425 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100430 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100425 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090916 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20130326 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20130430 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20130417 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602005016673 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20140425 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20141231 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602005016673 Country of ref document: DE Effective date: 20141101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140425 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140430 |